Skip to main navigation Skip to search Skip to main content

Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  • A. Zer
  • , M. J. Ahn
  • , F. Barlesi
  • , L. Bubendorf
  • , D. de Ruysscher
  • , P. Garrido
  • , O. Gautschi
  • , L. E. Hendriks
  • , P. A. Jänne
  • , K. M. Kerr
  • , C. Mascaux
  • , T. Mitsudomi
  • , S. Peters
  • , C. Rolfo
  • , A. Sacher
  • , S. Senan
  • , P. Ugalde
  • , N. B. Leighl
  • Technion-Israel Institute of Technology
  • Samsung Medical Center, Sungkyunkwan university
  • Institut de Cancerologie Gustave Roussy
  • University of Basel
  • Maastricht University
  • Erasmus University Rotterdam
  • Hospital Ramon y Cajal
  • Kantonsspital Luzern
  • University of Bern
  • Dana-Farber Cancer Institute
  • NHS Grampian
  • Les Hôpitaux Universitaires de Strasbourg
  • Kindai University
  • University of Lausanne
  • Ohio State University
  • Princess Margaret Hospital Cancer Centre
  • Vrije Universiteit Amsterdam
  • Harvard University

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

•This ESMO Clinical Practice Guideline provides key recommendations for managing early and locally advanced NSCLC. •The guideline covers diagnosis, staging, risk assessment, treatment and follow-up. •Treatment algorithms for resectable and unresectable disease are provided. •The authors encompass a multidisciplinary group of experts from different institutions and countries. •Recommendations are based on available scientific data and the authors’ collective expert opinion.
Original languageEnglish
JournalAnnals of oncology
Early online date2025
DOIs
Publication statusE-pub ahead of print - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • diagnosis
  • early non-small-cell lung cancer (NSCLC)
  • guideline
  • staging
  • treatment

Fingerprint

Dive into the research topics of 'Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up'. Together they form a unique fingerprint.

Cite this